Early Monoclonal Antibody Administration Can Reduce Both Hospitalizations and Mortality in High-Risk Outpatients With Coronavirus Disease 2019 (COVID-19).

Thumbnail Image
View / Download1.01 MB

Date

2022-03

Authors

Journal Title

Journal ISSN

Volume Title

Repository Usage Stats

6
views
8
downloads

Citation Stats

Abstract

Type

Journal article

Department

Description

Provenance

Subjects

COVID-19 Clinic Team, Humans, Antibodies, Monoclonal, Hospitalization, Outpatients, COVID-19, SARS-CoV-2

Citation

Permalink

https://hdl.handle.net/10161/28600

Published Version (Please cite this version)

10.1093/cid/ciab522

Publication Info

Jenks, Jeffrey D, Saima Aslam, Lucy E Horton, Nancy Law, Ajay Bharti, Cathy Logan, Mahnaz Taremi, Florin Vaida, et al. (2022). Early Monoclonal Antibody Administration Can Reduce Both Hospitalizations and Mortality in High-Risk Outpatients With Coronavirus Disease 2019 (COVID-19). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 74(4). pp. 752–753. 10.1093/cid/ciab522 Retrieved from https://hdl.handle.net/10161/28600.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.

Collections

Scholarly Articles
Full item page

Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.